Are pelvic irradiation and routine staging laparotomy necessary in clinically staged IA and IIA Hodgkin's disease?
Open Access
- 1 December 1977
- Vol. 40 (6) , 2914-2916
- https://doi.org/10.1002/1097-0142(197712)40:6<2914::aid-cncr2820400623>3.0.co;2-u
Abstract
Thirty‐nine patients with clinically staged IA and IIA Hodgkin's disease were treated with mantle plus paraaortic/splenic irradiation between 1968 and 1975. All patients had supradiaphragmatic presentations, and none had staging laparotomies. With a follow‐up time of 1 to 9 years, mean 4.3 years, the overall relapse‐free survival is 92% (100% for stage IA and 89% for stage IIA). The absolute relapse‐free 5‐year survival is 91% There were no pelvic recurrences. These data show that routine staging laparotomy and pelvic irradiation are not indicated for clinically staged IA and IIA Hodgkin's disease with supradiaphragmatic presentations. The criteria for staging laparotomy in early‐stage Hodgkin's disease are discussed. Cancer 40:2914‐2916, 1977.This publication has 6 references indexed in Scilit:
- Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin's disease?Cancer, 1976
- Is Staging Laparotomy Routinely Indicated in Hodgkin's Disease?Annals of Internal Medicine, 1971
- Surgical Staging of Abdominal Involvement in Unselected Patients with Hodgkin's DiseaseRadiology, 1970
- Preliminary Experience with Total Nodal Irradiation in Hodgkin's DiseaseRadiology, 1970
- The value of laparotomy and splenectomy in the staging of Hodgkin's diseaseCancer, 1969
- THE CLINICAL COURSE OF HODGKIN'S DISEASE AND OTHER MALIGNANT LYMPHOMAS TREATED WITH RADICAL RADIATION THERAPYAmerican Journal of Roentgenology, 1969